In recent weeks, there have been signs that the drug discovery industry has begun to slide, dragged ...
In recent weeks, there have been signs that the drug discovery industry has begun to slide, dragged down by investors looking to escape the roller-coaster ride of the equities markets. The Nasdaq biotech index has dropped by a quarter in March 2001 and is now resting at 60% below last year's peak. But are biotechs going the way of the dot.coms, or do they actually represent a miracle cure for the ailing technology sector? Amongst widespread doom and gloom for technology stocks, Nasdaq's golden child has, up until now, been the biotechnology sector, which has so far managed to keep it...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes